Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders

American Journal of Transplantation

Volumn 13, Issue 5, 2013, Pages 1305-1316

  Morscio, J ^a   Dierickx, D ^b   Ferreiro, J F ^c   Herreman, A ^a   Van Loo, P ^a,d   Bittoun, E ^a   Verhoef, G ^b   Matthys, P ^e   Cools, J ^a,d   Wlodarska, I ^c   De Wolf Peeters, C ^a,b   Sagaert, X ^a,b   Tousseyn, T ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

ABC; DLBCL; EBV; GCB; gene expression profiling; IC DLBCL; immunodeficiency; lymphoid neoplasia; lymphomagenesis; microarray; monomorphic PTLD; organ transplantation; posttransplantation lymphoproliferative disorder; PT DLBCL

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; CHEMOKINE RECEPTOR CXCR5; PROTEIN BCL 6;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRAIT; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INNATE IMMUNITY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOGENESIS; POST TREATMENT SURVIVAL; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; RETROSPECTIVE STUDIES; VIRAL PROTEINS; VIRUS LATENCY; YOUNG ADULT;

EID: 84876914888     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12196     Document Type: Article

References (27)

1. Swerdlow SH, Campo, E,., Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, Thiele, J, Vardiman, JW,. WHO classification of tumours of haematopoietic and lymphoid tissues: IARC Press, 2008.
2. Dharnidharka VR,. Epidemiology of PTLD. In:, Dharnidharka VR, Green, M., Webber, SA, eds. Post-transplant lymphoproliferative disorders. New York: Springer, 2010.
3. Manez R, Breinig MC, Linden P, Wilson J, Torre-Cisneros J, Kusne S, et al. Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease. J Infect Dis 1997; 176: 1462-1467. Epub 1997/12/12.
4. Jox A, Rohen C, Belge G, et al. Integration of Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of enhanced chromosome instability. Ann Oncol 1997; 8 (Suppl 2): 131-135. Epub 1997/01/01.
5. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-511. Epub 2000/02/17.
6. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-1947. Epub 2002/06/21.
7. Lenz G, Wright G, Dave SS, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008; 359: 2313-2323. Epub 2008/11/29.
8. Capello D, Rossi D, Gaidano G,. Post-transplant lymphoproliferative disorders: Molecular basis of disease histogenesis and pathogenesis. Hematol Oncol 2005; 23: 61-67. Epub 2005/10/11.
9. Vakiani E, Basso K, Klein U, et al. Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. Hematol Oncol 2008; 26: 199-211. Epub 2008/05/07.
10. Dierickx D, Tousseyn T, Sagaert X, et al. Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: Incidence, clinico-pathological characteristics and prognostic factors. Accepted in Leukemia and Lymphoma, February 9, 2013.
11. Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. The Engl J Med 2006; 354: 2419-2430. Epub 2006/06/09.
12. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-282. Epub 2003/09/25.
13. Hamilton-Dutoit SJ, Rea D, et al. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. Am J Pathol 1993; 143: 1072-1085. Epub 1993/10/01.
14. Craig FE, Johnson LR, Harvey SA, et al. Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders. Diagn Mol Pathol 2007; 16: 158-168. Epub 2007/08/28.
15. Webber SA,. Treatment of PTLD. In:, Dharnidharka VR, Green, M, Webber, SA, eds. Post-transplant lymphoproliferative disorders. New York: Springer, 2010.
16. Stawowczyk M, Van Scoy S, Kumar KP, Reich NC,. The interferon stimulated gene 54 promotes apoptosis. J Biol Chem 2011; 286: 7257-7266. Epub 2010/12/31.
17. Mitsui K, Nakanishi M, Ohtsuka S, et al. A novel human gene encoding HECT domain and RCC1-like repeats interacts with cyclins and is potentially regulated by the tumor suppressor proteins. Biochem Biophys Res Commu 1999; 266: 115-122. Epub 1999/12/03.
18. Chang C, Rodriguez A, Carretero M, Lopez-Botet M, Phillips JH, Lanier LL,. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C-type lectin superfamily. Eur J Immunol 1995; 25: 2433-2437. Epub 1995/09/01.
19. Turman MA, Yabe T, McSherry C, Bach FH, Houchins JP,. Characterization of a novel gene (NKG7) on human chromosome 19 that is expressed in natural killer cells and T cells. Hum Immunol 1993; 36: 34-40. Epub 1993/01/01.
20. Menten P, Wuyts A, Van Damme J,. Macrophage inflammatory protein-1. Cytokine Growth Factor Rev 2002; 13: 455-481. Epub 2002/10/29.
21. Van, Coillie E, Fiten P, Nomiyama H, et al. The human MCP-2 gene (SCYA8): Cloning, sequence analysis, tissue expression, and assignment to the CC chemokine gene contig on chromosome 17q11.2. Genomics 1997; 40: 323-331. Epub 1997/03/01.
22. Lang D, Knop J, Wesche H, et al. The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: A novel mechanism of regulation of IL-1 responsiveness. J Immunol 1998; 161: 6871-6877. Epub 1998/12/23.
23. Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE,. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J Biol Chem 1996; 271: 3967-3970. Epub 1996/02/23.
24. Vogt L, Schmitz N, Kurrer MO, et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J Clin Invest 2006; 116: 2817-2826. Epub 2006/10/04.
25. Green MR, Rodig S, Juszczynski P, et al. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res 2012; 18: 1611-1618. Epub 2012/01/25.
26. Munn DH,. Blocking IDO activity to enhance anti-tumor immunity. Front Biosci 2012; 4: 734-745. Epub 2011/12/29.
27. Dai Y, Tang Y, He F, et al. Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts. Virol J 2012; 9: 77. Epub 2012/03/31.